JAZZ News and Press, Jazz Pharmaceuticals plc From 10/25/23

2023-10-25 08:30:32 ET Palm Beach, FL – October 25, 2023 – FinancialNewsMedia.com News Commentary – The R&D for cancer vaccines has been growing in the last few years and is projected to continue through the next decade. A cancer vaccine is used to eithe...

Jazz Pharmaceuticals Presents Data Highlighting the Continued Need for Low-Sodium Treatment Option Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution and Real-World, Evidence-Based Approaches for Individualized Treatment in Adults with Narcolepsy at World Sleep 2023 ...

2023-10-20 13:48:29 ET More on Jazz Pharmaceuticals Jazz Pharma: Playing The High Notes With Xywav Jazz Pharmaceuticals plc (JAZZ) Q2 2023 Earnings Call Transcript Jazz Pharmaceuticals: Depressed Valuation Opens Up Potential Biggest stock movers today: Hewlet...

2023-10-20 09:13:00 ET U.S. stock index futures on Friday pointed to a lower open. Wall Street's benchmark S&P 500 ( SP500 ) gauge has fallen more than 1% so far this week, as sentiment has been weighed down by geopolitical concerns, economic data and a surge in Treasury yields....

2023-10-20 06:34:58 ET Summary CVS pulls oral medications containing decongestant phenylephrine due to lawsuits and doubts about its effectiveness. Toyota agrees to adopt Tesla's charging standard for its battery electric vehicles in North America. Jazz Pharmaceuticals explore...

2023-10-19 22:50:09 ET More on Jazz Pharmaceuticals Jazz Pharma: Playing The High Notes With Xywav Jazz Pharmaceuticals plc (JAZZ) Q2 2023 Earnings Call Transcript Jazz Pharmaceuticals: Depressed Valuation Opens Up Potential Ionis, AbbVie, Alnylam draw bullis...

Jazz Pharmaceuticals to Present Latest Advancements in Sleep Medicine at World Sleep 2023 PR Newswire Meeting presentations underscore the increased need for awareness around the cardiovascular and cardiometabolic comorbidities and modifiable risk factors associated with sleep...

Jazz Pharmaceuticals to Showcase Growing Impact in Solid Tumor Oncology Research at ESMO 2023 PR Newswire Zanidatamab data demonstrate clinical potential of novel bispecific antibody in HER2-targeted biliary tract and gastric cancers Additional presentations, including...

2023-10-08 03:55:12 ET Summary Jazz Pharmaceuticals shows robust Q2 revenue and net income growth; supply chain issues and share dilution warrant scrutiny. Strong liquidity suggests the low need for external financing; however, a high debt load balances the financial equation. ...

Originally published in Jazz Pharmaceuticals' 2022 Corporate Sustainability and Social Impact Report NORTHAMPTON, MA / ACCESSWIRE / October 6, 2023 / A Letter From Our Chairman of the Board and Chief Executive Officer Bruce C. Cozadd I am pleased to share Jazz's 2022 Corporate Sustainabili...